TABLE 1.
Characteristic | No. | Prevalence |
---|---|---|
Age, y | ||
<50 | 68 | 20 |
50–59 | 115 | 33.8 |
60–69 | 85 | 25 |
>70 | 72 | 21.2 |
Sex | ||
Women | 89 | 26.2 |
Men | 251 | 73.8 |
Pack-years smoked* | ||
0–5 | 82 | 24.9 |
5–34 | 99 | 31.1 |
>34 | 148 | 45 |
Average alcoholic drinks per wk† | ||
0–2.5 | 49 | 14.7 |
2.5–6 | 50 | 15 |
6–14 | 57 | 17 |
>14 | 178 | 53.3 |
HPV-16 seropositivity | ||
Negative | 253 | 74.4 |
Positive | 87 | 25.6 |
CDH1 hypermethylation | ||
Negative | 227 | 66.8 |
Positive | 113 | 33.2 |
Tumor stage‡ | ||
1 | 25 | 16.5 |
2 | 31 | 20.4 |
3 | 37 | 24.3 |
4 | 58 | 38.8 |
Tumor site§ | ||
Oral cavity and tongue | 194 | 57.4 |
Pharynx | 86 | 25.4 |
Larynx | 58 | 17.2 |
HPV-16 indicates human papillomavirus type 16; the CDH1, cadherin 1, type 1/E-cadherin gene.
Data on pack-years of smoking were missing for 11 individuals.
Data on alcohol consumption were missing for 6 individuals.
The components used to derive tumor stage were not fully available for 188 patients.
Tumor site was not available for 2 patients.